Diabetes Mellitus, Type 2
Conditions
Keywords
HbA1c, Cholesterol, Resting Heart Rate
Brief summary
Investigation into the effects of a 12-week digital physical activity programme, with or without physical education support on blood glucose control in patients with T2DM using HbA1c testing.
Detailed description
Primary objective: investigate the effects of a 12-week digital physical activity programme, with or without physical education support on blood glucose control in patients with T2DM using HbA1c testing. Secondary objective: evaluate the effects on Cholesterol (ratio of High Density Lipids to Low Density Lipids), Resting Heart Rate, and Body Mass Index after a 12 week physical activity programme. Monitor step counts and sleep patterns during a 12 week physical activity programme.: Methods: Using a RCT is intended to implement dependent variable inductive research into a 12-week e-Health Physical activity (PA) programme with or without physical education support focusing on the blood glucose control in patients with T2DM. Recruitment of 60 patients from hospital out-patient clinics, community diabetic departments, and. NHS patients from general practitioners.
Interventions
Bloods will be take pre and post 12 week intervention.
Sponsors
Study design
Intervention model description
At the point of consent the participants will be randomised to one of three allocated groups. Control group, Intervention 1 or Intervention 2.
Eligibility
Inclusion criteria
* A diagnosis of T2DM in the last 3 years. * Age 18+ years. * Uses the English language as a primary or secondary language with the ability to read and write. * Lives in the United Kingdom. * Has no medical reason preventing participation in regular physical activity. * Has a SMART phone with access to the internet.
Exclusion criteria
* Physical inability to participate in 12 weeks of physical activity. * Cardiac or cardiovascular surgery in the past 6 months. * Musculoskeletal issues that could be aggravated whilst participating in regular physical activity. * Presently participating in a weight loss programme. * Unable to commit to the 12-week feasibility study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c testing | 12 weeks | blood will be take pre and post trial. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cholesterol ratio testing | 12 weeks | blood will be take pre and post trial. |
Countries
United Kingdom